University of California, San Diego - ACTRI
Welcome,         Profile    Billing    Logout  
 1 Trial 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thomas, Robert
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

Completed
3
214
US
Open-label pitolisant, Double-blind placebo, Double-blind pitolisant
Harmony Biosciences, LLC
Idiopathic Hypersomnia
09/23
09/23
NCT05668754: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH

Completed
2
50
US
Serdexmethylphenidate, SDX, Placebo
Zevra Therapeutics, Rho, Inc.
Idiopathic Hypersomnia
02/24
03/24
THRIVE, NCT06076499: A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS

Recruiting
N/A
325
US
NTX100
Noctrix Health, Inc.
Restless Legs Syndrome
06/25
12/26
Manager, Program
PROSPER, NCT06244771: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Recruiting
1/2
403
US
FMC-376
Frontier Medicines Corporation
Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor, Metastatic Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer, KRAS G12C, Pancreatic Cancer
10/27
04/28
NCT05268666: A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

Recruiting
1/2
126
US
JBI-802
Jubilant Therapeutics Inc.
Locally Advanced Solid Tumor, Metastatic Solid Tumor
12/24
08/25
NCT06476275: Single Dose Texas 2017 (H3N2) Challenge Study

Active, not recruiting
1
33
US
Influenza A/Texas/71/2017 (H3N2), Sham placebo
Duke University, United States Department of Defense, Owlstone Ltd, Darwin Biosciences
Influenza Viral Infections
02/25
04/25

Download Options